KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medtronic (MDT) Other Working Capital Changes (2016 - 2025)

Historic Other Working Capital Changes for Medtronic (MDT) over the last 12 years, with Q4 2025 value amounting to $727.0 million.

  • Medtronic's Other Working Capital Changes rose 1996.7% to $727.0 million in Q4 2025 from the same period last year, while for Oct 2025 it was $929.0 million, marking a year-over-year increase of 4097.12%. This contributed to the annual value of $538.0 million for FY2025, which is 5594.2% up from last year.
  • According to the latest figures from Q4 2025, Medtronic's Other Working Capital Changes is $727.0 million, which was up 1996.7% from $464.0 million recorded in Q3 2025.
  • Medtronic's Other Working Capital Changes' 5-year high stood at $727.0 million during Q4 2025, with a 5-year trough of -$405.0 million in Q4 2022.
  • Moreover, its 5-year median value for Other Working Capital Changes was $103.5 million (2021), whereas its average is $135.4 million.
  • Its Other Working Capital Changes has fluctuated over the past 5 years, first soared by 115142.86% in 2023, then plummeted by 1140000.0% in 2025.
  • Medtronic's Other Working Capital Changes (Quarter) stood at $88.0 million in 2021, then plummeted by 560.23% to -$405.0 million in 2022, then surged by 243.7% to $582.0 million in 2023, then grew by 4.12% to $606.0 million in 2024, then increased by 19.97% to $727.0 million in 2025.
  • Its last three reported values are $727.0 million in Q4 2025, $464.0 million for Q3 2025, and -$147.0 million during Q2 2025.